Illumina Pushes Back Shipment Date for iScan Sequencing Module to Q2 2010

The delay allows the company to improve the performance of the module, according to Illumina President and CEO Jay Flatley, who spoke at the UBS Global Life Sciences conference in New York this week.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.